What is the ICD‑10‑CM code for tinea pedis in a diabetic patient, and which code should be used for the underlying diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Coding for Tinea Pedis in Diabetic Patients

For tinea pedis in a diabetic patient, use B35.3 (tinea pedis) as the primary diagnosis code for the fungal infection, and code the specific type of diabetes mellitus (E10.x for Type 1 or E11.x for Type 2) with the appropriate fourth character to indicate any diabetic complications present.

Coding Structure

Tinea Pedis Code

  • B35.3 is the specific ICD-10-CM code for tinea pedis (athlete's foot)
  • This code should be listed when documenting the fungal infection

Diabetes Mellitus Codes

The diabetes code requires careful selection based on:

Type of Diabetes:

  • E10.x = Type 1 diabetes mellitus
  • E11.x = Type 2 diabetes mellitus

Fourth Character Specification: The fourth character (x) indicates diabetic complications:

  • E10.621 or E11.621 = with foot ulcer
  • E10.622 or E11.622 = with other skin ulcer
  • E10.628 or E11.628 = with other skin complications
  • E10.65 or E11.65 = with hyperglycemia
  • E10.69 or E11.69 = with other specified complication
  • E10.8 or E11.8 = with unspecified complications
  • E10.9 or E11.9 = without complications

Clinical Context and Coding Rationale

Diabetic patients are nearly three times more likely to develop onychomycosis and tinea pedis compared to non-diabetics 1. The presence of tinea pedis in diabetics is clinically significant because it increases the risk of bacterial superinfection, foot ulceration, and potentially limb-threatening complications 1, 2.

Key Considerations:

  • If the patient has active diabetic foot ulceration, use E10.621 or E11.621 along with B35.3
  • If tinea pedis is present but without ulceration, use E10.628 or E11.628 (with other skin complications) or E10.9/E11.9 (without complications) depending on whether other diabetic complications exist
  • Always code both conditions when present, as the fungal infection represents a significant risk factor for diabetic foot complications 3, 4

Common Pitfalls to Avoid:

  1. Don't omit the tinea pedis code - it's a distinct diagnosis requiring specific treatment and represents an important risk factor for DFU development
  2. Don't use generic skin infection codes - B35.3 is the specific code for tinea pedis
  3. Ensure accurate diabetes type classification - Type 1 vs Type 2 distinction is critical, with ICD-10-CM codes showing >90% accuracy for this differentiation 5
  4. Document all relevant complications - if peripheral neuropathy, peripheral arterial disease, or other complications coexist, these should be coded with their respective fourth characters

Clinical Significance

Tinea pedis in diabetics warrants aggressive management because diseased skin can serve as an entry point for pathogens, potentially leading to limb-threatening infections in patients with compromised circulation, neuropathy, and impaired wound healing 1. Daily foot washing has been associated with reduced tinea pedis prevalence 3, emphasizing the importance of preventive foot care education in this population.

Related Questions

Which ICD‑10‑CM diagnosis code should be used to refer a diabetic patient to podiatry for toenail trimming?
What is the ICD‑10‑CM code for scaly, cracked, hyperkeratotic skin on the soles of the feet in a patient with type 2 diabetes mellitus?
Which ICD-10 code is appropriate for a blister on the leg when the cause is unknown?
What ICD‑10‑CM codes correspond to an adult patient with type 2 diabetes mellitus, elevated vitamin B12, hyperlipidemia, and who is taking low‑dose aspirin, ergocalciferol, fish‑oil supplement, glimepiride, a lisinopril/hydrochlorothiazide combination, metoprolol tartrate, and nifedipine?
What ICD‑10 code should be used for a diabetic ulcer on the left second toe?
What is the recommended follow‑up and management strategy for a patient with chronic kidney disease, including blood pressure control, diabetes management, dietary restrictions, anemia treatment, monitoring parameters, and timing of renal replacement therapy?
What do low‑density lipoprotein (LDL) cholesterol and high‑density lipoprotein (HDL) cholesterol mean, including their roles, normal ranges, and implications for cardiovascular risk?
How should periorbital bruising (raccoon eyes) be evaluated and managed?
How can I reprogram a Medtronic pacemaker from MVP (Managed Ventricular Pacing) mode to DDD (dual‑chamber pacing) mode?
What monitoring plan should be followed for a patient receiving Enhertu (trastuzumab‑deruxtecan) therapy?
What are the risks associated with a retained bullet in the liver?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.